Home   >  
Others Pathway
ADC Related

Classified by application

All Products

Signaling Pathways

Research Areas

Nature products






Raw Materials

ADC Related

Chemical Structure Cat. No. Product Name CAS No.
SPDB Chemical Structure
BCP33395 SPDB 115088-06-7
SPDB is a glutathione cleavable ADC linker used for the antibody-drug conjugate (ADCs).
Lys-SMCC-DM1 Chemical Structure
BCP33031 Lys-SMCC-DM1 1281816-04-3
Lys-SMCC-DM1 is the active metabolite of DM1.
Boc-Val-Cit-PAB-PNP Chemical Structure
BCP32930 Boc-Val-Cit-PAB-PNP 870487-10-8
Boc-Val-Cit-PAB-PNP is a cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs).
Vc-MMAD Chemical Structure
BCP32929 Vc-MMAD 1401963-17-4
Vc-MMAD consists the ADCs linker (Val-Cit) and potent tubulin inhibitor (MMAD). Vc-MMAD is a drug-linker conjugate for ADC.
Microcystin RR Chemical Structure
BCP32942 Microcystin RR 111755-37-4
Microcystin-RR inhibits PP1C, PP1γ, and PP2A with Ki values of 0.15, 0.24, and 0.018 nM, respectively.
VAL-CIT-PAB-MMAD Chemical Structure
BCP32931 VAL-CIT-PAB-MMAD 1415329-13-3
VAL-CIT-PAB-MMAD is a drug-linker conjugate for ADC with potent antitumor activity by using Monomethyl Dolastatin 10 (a potent tubulin inhibitor), linked via the ADC linker Vat-Cit-PAB.
CL1-SN-38 Chemical Structure
BCP32856 CL1-SN-38 1373216-45-5
This ADC product is composed of an anti-CEACAM5 antibody conjuagated via a CL1 linker to SN-38 (CL1-SN-38). It has demonstrated a response in colon carcinoma treatment by a MOA (Mechanism of Action) of Inhibit Topoisomerase I and cause DNA damage.
CL2-SN-38 Chemical Structure
BCP20816 CL2-SN-38 1036969-20-6
CL2-SN-38 is a part of the antibody drug conjugate (ADC), can conjugate with the anti-Trop-2-humanized antibody hRS7.
Dxd Chemical Structure
BCP32858 Dxd 1599440-33-1
Dxd is a potent DNA topoisomerase I inhibitor, with an IC50 of 0.31 μM, used as a conjugated drug of HER2-targeting ADC (DS-8201a).
CL2A-SN-38 Chemical Structure
BCP32728 CL2A-SN-38 1279680-68-0
CL2A-SN-38 is a drug-linker conjugate composed of a potent a DNA Topoisomerase I inhibitor SN-38 and a linker CL2A to make antibody drug conjugate (ADC).
123下一页末页共 58 条记录 1 / 6 页